Genes,
Journal Year:
2021,
Volume and Issue:
12(6), P. 796 - 796
Published: May 24, 2021
The
current
SARS-CoV-2
pandemic
is
still
threatening
humankind.
Despite
first
successes
in
vaccine
development
and
approval,
no
antiviral
treatment
available
for
COVID-19
patients.
success
further
tarnished
by
the
emergence
spreading
of
mutation
variants
SARS-CoV-2,
which
some
vaccines
have
lower
efficacy.
This
highlights
urgent
need
therapies
even
more.
article
describes
how
genome-scale
metabolic
model
(GEM)
host-virus
interaction
human
alveolar
macrophages
was
refined
incorporating
latest
information
about
virus's
structural
proteins
mutant
B.1.1.7,
B.1.351,
B.1.28,
B.1.427/B.1.429,
B.1.617.
We
confirmed
initially
identified
guanylate
kinase
as
a
potential
target
with
this
targets
from
purine
pyrimidine
metabolism.
extended
virus'
lipid
requirements.
opened
new
perspectives
altered
Especially
phosphatidylcholine
biosynthesis
seems
to
play
pivotal
role
viral
replication.
robust
all
investigated
currently
worldwide.
These
insights
can
guide
laboratory
experiments
validation
targets.
Only
combination
will
effectively
defeat
ongoing
pandemic.
Molecular Systems Biology,
Journal Year:
2020,
Volume and Issue:
16(8)
Published: Aug. 1, 2020
Review26
August
2020Open
Access
SBML
Level
3:
an
extensible
format
for
the
exchange
and
reuse
of
biological
models
Sarah
M
Keating
orcid.org/0000-0002-3356-3542
Computing
Mathematical
Sciences,
California
Institute
Technology,
Pasadena,
CA,
USA
European
Bioinformatics
Institute,
Molecular
Biology
Laboratory
(EMBL-EBI),
Hinxton,
UK
BioQuant/COS,
Heidelberg
University,
Heidelberg,
Germany
Search
more
papers
by
this
author
Dagmar
Waltemath
orcid.org/0000-0002-5886-5563
Medical
Informatics,
Community
Health,
University
Medicine
Greifswald,
Matthias
König
orcid.org/0000-0003-1725-179X
Theoretical
Biology,
Humboldt-University
Berlin,
Fengkai
Zhang
orcid.org/0000-0001-7112-9328
Immune
System
National
Allergy
Infectious
Diseases,
Institutes
Bethesda,
MD,
Andreas
Dräger
orcid.org/0000-0002-1240-5553
Computational
Systems
Infection
Antimicrobial-Resistant
Pathogens,
Biomedical
Informatics
(IBMI),
Tübingen,
Department
Computer
Science,
German
Center
Research
(DZIF),
Claudine
Chaouiya
orcid.org/0000-0003-2350-0756
Aix-Marseille
Université,
CNRS,
Centrale
Marseille,
France
Instituto
Gulbenkian
de
Ciência,
Oeiras,
Portugal
Frank
T
Bergmann
orcid.org/0000-0001-5553-4702
Andrew
Finney
ANSYS
Ltd,
Milton
Park,
Oxfordshire,
Colin
S
Gillespie
orcid.org/0000-0003-1787-0275
School
Mathematics,
Statistics
Physics,
Newcastle
upon
Tyne,
Tomáš
Helikar
orcid.org/0000-0003-3653-1906
Biochemistry,
Nebraska–Lincoln,
Lincoln,
NE,
Stefan
Hoops
orcid.org/0000-0001-8503-8371
Biocomplexity
&
Initiative,
Virginia,
Charlottesville,
VA,
Rahuman
Malik-Sheriff
orcid.org/0000-0003-0705-9809
Stuart
L
Moodie
orcid.org/0000-0001-6191-5595
Eight
Pillars
Edinburgh,
Ion
I
Moraru
orcid.org/0000-0002-3746-9676
Cell
Analysis
Modeling,
UConn
Farmington,
CT,
Chris
J
Myers
orcid.org/0000-0002-8762-8444
Electrical
Engineering,
Utah,
Salt
Lake
City,
UT,
Aurélien
Naldi
orcid.org/0000-0002-6495-2655
Institut
Biologie
l'ENS
(IBENS),
Département
Biologie,
École
Normale
Supérieure,
INSERM,
Université
PSL,
Paris,
Brett
G
Olivier
orcid.org/0000-0002-5293-5321
SysBioLab,
AIMMS,
Vrije
Universiteit
Amsterdam,
Netherlands
Sven
Sahle
James
C
Schaff
orcid.org/0000-0003-3286-7736
Applied
BioMath,
LLC,
Concord,
MA,
Lucian
P
Smith
orcid.org/0000-0001-7002-6386
Bioengineering,
Washington,
Seattle,
WA,
Maciej
Swat
Simcyp
(a
Certara
company),
Sheffield,
South
Yorkshire,
Denis
Thieffry
orcid.org/0000-0003-0271-1757
Leandro
Watanabe
orcid.org/0000-0001-7030-8690
Darren
Wilkinson
orcid.org/0000-0003-0736-802X
The
Alan
Turing
British
Library,
London,
Michael
Blinov
orcid.org/0000-0002-9363-9705
Kimberly
Begley
orcid.org/0000-0002-1642-7493
R
Faeder
orcid.org/0000-0001-8127-609X
Pittsburgh,
PA,
Harold
F
Gómez
Biosystems
Science
ETH
Zürich,
Basel,
Switzerland
Thomas
Hamm
orcid.org/0000-0001-9579-7267
Yuichiro
Inagaki
orcid.org/0000-0003-4011-8487
Management
IT
Consulting
Division,
Mizuho
Information
Inc.,
Tokyo,
Japan
Wolfram
Liebermeister
orcid.org/0000-0002-2568-2381
Paris-Saclay,
INRAE,
MaIAGE,
Jouy-en-Josas,
Allyson
Lister
orcid.org/0000-0002-7702-4495
Oxford
e-Research
Centre
(OeRC),
Engineering
Oxford,
Daniel
Lucio
orcid.org/0000-0002-8912-7213
College
NC
State
Raleigh,
NC,
Eric
Mjolsness
orcid.org/0000-0002-9085-9171
California,
Irvine,
Carole
Proctor
orcid.org/0000-0002-1366-1399
Cellular
Medicine,
Karthik
Raman
orcid.org/0000-0002-9311-7093
Biotechnology,
Bhupat
Jyoti
Mehta
Biosciences,
Indian
Technology
(IIT)
Madras,
Chennai,
India
Initiative
Biological
(IBSE),
IIT
Robert
Bosch
Data
Artificial
Intelligence
(RBC-DSAI),
Nicolas
Rodriguez
orcid.org/0000-0002-9290-7894
Babraham
Cambridge,
Clifford
A
Shaffer
orcid.org/0000-0003-0001-0295
Virginia
Tech,
Blacksburg,
Bruce
E
Shapiro
Northridge,
Joerg
Stelling
orcid.org/0000-0002-1145-891X
SIB
Swiss
Bioinformatics,
Neil
Swainston
orcid.org/0000-0001-7020-1236
Integrative
Liverpool,
Naoki
Tanimura
Solutions
John
Wagner
IBM
Australia,
Melbourne,
Vic.,
Australia
Martin
Meier-Schellersheim
orcid.org/0000-0002-8754-6377
Herbert
Sauro
orcid.org/0000-0002-3659-6817
Bernhard
Palsson
orcid.org/0000-0003-2357-6785
San
Diego,
La
Jolla,
Hamid
Bolouri
Immunology,
Benaroya
at
Mason,
Hiroaki
Kitano
orcid.org/0000-0002-3589-1953
Okinawa
Okinawa,
Akira
Funahashi
orcid.org/0000-0003-0605-239X
Biosciences
Keio
Yokohama,
Kanagawa,
Henning
Hermjakob
orcid.org/0000-0001-8479-0262
Doyle
orcid.org/0000-0002-1828-2486
Hucka
Corresponding
Author
[email
protected]
orcid.org/0000-0001-9105-5960
3
members
membersA
complete
list
affiliations
appears
in
Appendix
1Search
Keating1,2,3,‡,
Waltemath4,‡,
König5,
Zhang6,
Dräger7,8,9,
Chaouiya10,11,
Bergmann3,
Finney12,
Gillespie13,
Helikar14,
Hoops15,
Malik-Sheriff2,
Moodie16,
Moraru17,
Myers18,
Naldi19,
Olivier1,3,20,
Sahle3,
Schaff21,
Smith1,22,
Swat23,
Thieffry19,
Watanabe18,
Wilkinson13,24,
Blinov17,
Begley25,
Faeder26,
Gómez27,
Hamm7,8,
Inagaki28,
Liebermeister29,
Lister30,
Lucio31,
Mjolsness32,
Proctor33,
Raman34,35,36,
Rodriguez37,
Shaffer38,
Shapiro39,
Stelling40,
Swainston41,
Tanimura42,
Wagner43,
Meier-Schellersheim6,
Sauro22,
Palsson44,
Bolouri45,
Kitano46,47,
Funahashi48,
Hermjakob2,
Doyle1,
*,1,
,
Richard
Adams,
Nicholas
Allen,
Bastian
Angermann,
Marco
Antoniotti,
Gary
D
Bader,
Jan
Červený,
Mélanie
Courtot,
Cox,
Piero
Dalle
Pezze,
Emek
Demir,
William
Denney,
Harish
Dharuri,
Julien
Dorier,
Dirk
Drasdo,
Ali
Ebrahim,
Johannes
Eichner,
Johan
Elf,
Lukas
Endler,
Evelo,
Christoph
Flamm,
Ronan
MT
Fleming,
Martina
Fröhlich,
Mihai
Glont,
Emanuel
Gonçalves,
Golebiewski,
Hovakim
Grabski,
Alex
Gutteridge,
Damon
Hachmeister,
Leonard
Harris,
Benjamin
Heavner,
Ron
Henkel,
Hlavacek,
Bin
Hu,
Hyduke,
Hidde
Jong,
Nick
Juty,
Peter
Karp,
Jonathan
Karr,
Douglas
B
Kell,
Roland
Keller,
Ilya
Kiselev,
Steffen
Klamt,
Edda
Klipp,
Christian
Knüpfer,
Fedor
Kolpakov,
Falko
Krause,
Kutmon,
Camille
Laibe,
Conor
Lawless,
Lu
Li,
Leslie
Loew,
Rainer
Machne,
Yukiko
Matsuoka,
Pedro
Mendes,
Huaiyu
Mi,
Florian
Mittag,
Monteiro,
Kedar
Nath
Natarajan,
Poul
MF
Nielsen,
Tramy
Nguyen,
Alida
Palmisano,
Jean-Baptiste
Pettit,
Pfau,
Phair,
Tomas
Radivoyevitch,
Johann
Rohwer,
Oliver
Ruebenacker,
Julio
Saez-Rodriguez,
Scharm,
Schmidt,
Falk
Schreiber,
Schubert,
Roman
Schulte,
Sealfon,
Kieran
Smallbone,
Sylvain
Soliman,
Melanie
Stefan,
Devin
Sullivan,
Koichi
Takahashi,
Bas
Teusink,
David
Tolnay,
Ibrahim
Vazirabad,
Axel
Kamp,
Ulrike
Wittig,
Clemens
Wrzodek,
Finja
Ioannis
Xenarios,
Anna
Zhukova
Jeremy
Zucker
1Computing
2European
3BioQuant/COS,
4Medical
5Institute
6Laboratory
7Computational
8Department
9German
10Aix-Marseille
11Instituto
12ANSYS
13School
14Department
15Biocomplexity
16Eight
17Center
18Department
19Institut
20SysBioLab,
21Applied
22Department
23Simcyp
24The
25California
26Department
27Department
28Management
29Université
30Oxford
31College
32Department
33Institute
34Department
35Initiative
36Robert
37The
38Department
39Department
40Department
41Institute
42Science
43IBM
44Department
45Systems
46The
47Okinawa
48Department
‡These
authors
contributed
equally
to
work
*Corresponding
author.
Tel:
+1
626
395
3418;
E-mail:
(2020)16:e9110https://doi.org/10.15252/msb.20199110
Correction
added
on
4
September
2020,
after
first
online
publication:
symbol
row
Distributions,
column
Specification
was
corrected
a
checkmark
PDFDownload
PDF
article
text
main
figures.
ToolsAdd
favoritesDownload
CitationsTrack
CitationsPermissions
ShareFacebookTwitterLinked
InMendeleyWechatReddit
Figures
Info
Abstract
biology
has
experienced
dramatic
growth
number,
size,
complexity
computational
models.
To
reproduce
simulation
results
models,
researchers
must
unambiguous
model
descriptions.
We
review
latest
edition
Markup
Language
(SBML),
designed
purpose.
community
modelers
software
developed
over
past
decade.
Its
modular
form
consists
core
suited
representing
reaction-based
packages
that
extend
with
features
other
types
including
constraint-based
reaction-diffusion
logical
network
rule-based
leverages
two
decades
rich
ecosystem
transformed
how
systems
biologists
build
interact
More
recently,
rise
multiscale
whole
cells
organs,
new
data
sources
such
as
single-cell
measurements
live
imaging,
precipitated
ways
integrating
provide
our
perspectives
challenges
presented
these
developments
provides
foundation
needed
support
evolution.
Introduction
modeling
numerical
simulations
can
be
traced
mid-20th
century.
Though
general
theorizing
about
began
earlier,
application
analysis
biolo
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(9), P. 4645 - 4645
Published: April 22, 2022
Big
data
in
health
care
is
a
fast-growing
field
and
new
paradigm
that
transforming
case-based
studies
to
large-scale,
data-driven
research.
As
big
dependent
on
the
advancement
of
standards,
technology,
relevant
research,
future
development
applications
holds
foreseeable
promise
modern
day
revolution.
Enormously
large,
rapidly
growing
collections
biomedical
omics-data
(genomics,
proteomics,
transcriptomics,
metabolomics,
glycomics,
etc.)
clinical
create
major
challenges
opportunities
for
their
analysis
interpretation
open
computational
gateways
address
these
issues.
The
design
robust
algorithms
are
most
suitable
properly
analyze
this
by
taking
into
account
individual
variability
genes
has
enabled
creation
precision
(personalized)
medicine.
We
reviewed
highlighted
significance
analytics
personalized
medicine
focusing
mostly
machine
learning
perspectives
medicine,
genomic
models
with
respect
application
mining
as
well
we
facing
right
now
analytics.
npj Digital Medicine,
Journal Year:
2022,
Volume and Issue:
5(1)
Published: May 20, 2022
Abstract
Digital
twins,
customized
simulation
models
pioneered
in
industry,
are
beginning
to
be
deployed
medicine
and
healthcare,
with
some
major
successes,
for
instance
cardiovascular
diagnostics
insulin
pump
control.
Personalized
computational
also
assisting
applications
ranging
from
drug
development
treatment
optimization.
More
advanced
medical
digital
twins
will
essential
making
precision
a
reality.
Because
the
immune
system
plays
an
important
role
such
wide
range
of
diseases
health
conditions,
fighting
pathogens
autoimmune
disorders,
have
especially
high
impact.
However,
their
presents
challenges,
stemming
inherent
complexity
difficulty
measuring
many
aspects
patient’s
state
vivo.
This
perspective
outlines
roadmap
meeting
these
challenges
building
prototype
twin.
It
is
structured
as
four-stage
process
that
proceeds
specification
concrete
use
case
model
constructions,
personalization,
continued
improvement.
Prostate
cancer
is
the
second
most
occurring
in
men
worldwide.
To
better
understand
mechanisms
of
tumorigenesis
and
possible
treatment
responses,
we
developed
a
mathematical
model
prostate
which
considers
major
signalling
pathways
known
to
be
deregulated.
We
personalised
this
Boolean
molecular
data
reflect
heterogeneity
specific
response
perturbations
patients.
A
total
488
samples
were
used
build
patient-specific
models
compared
available
clinical
data.
Additionally,
eight
cell
line-specific
built
validate
our
approach
with
dose-response
several
drugs.
The
effects
single
combined
drugs
tested
these
under
different
growth
conditions.
identified
15
actionable
points
interventions
one
whose
inactivation
hinders
tumorigenesis.
results,
nine
small
molecule
inhibitors
five
those
putative
targets
found
dose-dependent
effect
on
four
them,
notably
targeting
HSP90
PI3K.
These
results
highlight
predictive
power
illustrate
how
they
can
for
precision
oncology.
Acta Physiologica,
Journal Year:
2024,
Volume and Issue:
240(3)
Published: Jan. 25, 2024
Abstract
Our
aim
is
to
present
an
updated
overview
of
the
erythrocyte
metabolism
highlighting
its
richness
and
complexity.
We
have
manually
collected
connected
available
biochemical
pathways
integrated
them
into
a
functional
metabolic
map.
The
focus
this
map
on
main
consisting
glycolysis,
pentose
phosphate
pathway,
redox
metabolism,
oxygen
purine/nucleoside
membrane
transport.
Other
recently
emerging
are
also
curated,
like
methionine
salvage
glyoxalase
system,
carnitine
lands
cycle,
as
well
remnants
carboxylic
acid
metabolism.
An
additional
goal
review
dynamics
providing
key
numbers
used
perform
basic
quantitative
analyses.
By
synthesizing
experimental
computational
data,
we
conclude
that
foundations
Additionally,
can
sense
levels
oxidative
stress
adjusting
mechanics,
function.
In
conclusion,
fine‐tuning
controls
one
most
important
biological
processes,
is,
loading,
transport,
delivery.
Molecular Systems Biology,
Journal Year:
2021,
Volume and Issue:
17(2)
Published: Feb. 1, 2021
Reproducibility
of
scientific
results
is
a
key
element
science
and
credibility.
The
lack
reproducibility
across
many
fields
has
emerged
as
an
important
concern.
In
this
piece,
we
assess
mathematical
model
propose
scorecard
for
improving
in
field.
Nucleic Acids Research,
Journal Year:
2019,
Volume and Issue:
48(D1), P. D1 - D8
Published: Dec. 22, 2019
Abstract
The
2020
Nucleic
Acids
Research
Database
Issue
contains
148
papers
spanning
molecular
biology.
They
include
59
reporting
on
new
databases
and
79
covering
recent
changes
to
resources
previously
published
in
the
issue.
A
further
ten
are
updates
most
recently
elsewhere.
This
issue
three
breakthrough
articles:
AntiBodies
Chemically
Defined
(ABCD)
curates
antibody
sequences
their
cognate
antigens;
SCOP
returns
with
a
schema
breaks
away
from
purely
hierarchical
structure;
while
Alliance
of
Genome
Resources
brings
together
number
Model
Organism
pool
knowledge
tools.
Major
returning
nucleic
acid
miRDB
miRTarBase.
Databases
for
protein
sequence
analysis
CDD,
DisProt
ELM,
alongside
no
fewer
than
four
newcomers
proteins
involved
liquid–liquid
phase
separation.
In
metabolism
signaling,
Pathway
Commons,
Reactome
Metabolights
all
contribute
papers.
PATRIC
MicroScope
update
microbial
genomes
human
model
organism
genomics
Ensembl,
Ensembl
UCSC
Browser.
Immune-related
covered
by
IPD-IMGT/HLA
AFND,
as
well
VDJbase
OGRDB.
Drug
design
is
catered
IUPHAR/BPS
Guide
Pharmacology
Therapeutic
Target
Database.
entire
freely
available
online
website
(https://academic.oup.com/nar).
NAR
Molecular
Biology
Collection
has
been
revised,
updating
305
entries,
adding
65
eliminating
125
discontinued
URLs;
so
bringing
current
total
1637
databases.
It
at
http://www.oxfordjournals.org/nar/database/c/.
Journal of Biological Chemistry,
Journal Year:
2021,
Volume and Issue:
296, P. 100743 - 100743
Published: Jan. 1, 2021
Integrative
modeling
is
an
increasingly
important
tool
in
structural
biology,
providing
structures
by
combining
data
from
varied
experimental
methods
and
prior
information.
As
a
result,
molecular
architectures
of
large,
heterogeneous,
dynamic
systems,
such
as
the
∼52-MDa
Nuclear
Pore
Complex,
can
be
mapped
with
useful
accuracy,
precision,
completeness.
Key
challenges
improving
integrative
include
expanding
model
representations,
increasing
variety
input
information,
quantifying
match
between
information
Bayesian
fashion,
inventing
more
efficient
sampling,
well
developing
better
validation,
analysis,
visualization.
In
addition,
two
community-level
are
being
addressed
under
auspices
Worldwide
Protein
Data
Bank
(wwPDB).
First,
impact
maximized
PDB-Development,
prototype
wwPDB
repository
for
archiving,
validating,
visualizing,
disseminating
structures.
Second,
scope
biology
expanded
linking
resource
archives
that
have
not
been
generally
used
structure
determination
but
computing
structures,
various
types
mass
spectrometry,
spectroscopy,
optical
microscopy,
proteomics,
genetics.
To
address
largest
problems,
type
called
metamodeling
developed;
combines
different
models
opposed
to
compute
output
model.
Collectively,
these
developments
will
facilitate
mindset
cell
underpin
spatiotemporal
mapping
entire
cell.
Nucleic Acids Research,
Journal Year:
2021,
Volume and Issue:
50(D1), P. D11 - D19
Published: Nov. 23, 2021
Abstract
The
European
Bioinformatics
Institute
(EMBL-EBI)
maintains
a
comprehensive
range
of
freely
available
and
up-to-date
molecular
data
resources,
which
includes
over
40
resources
covering
every
major
type
in
the
life
sciences.
This
year's
service
update
for
EMBL-EBI
new
PGS
Catalog
AlphaFold
DB,
updates
on
existing
including
COVID-19
Data
Platform,
trRosetta
RoseTTAfold
models
introduced
Pfam
InterPro,
launch
Genome
Integrations
with
Function
Sequence
by
UniProt
Ensembl.
Furthermore,
we
highlight
projects
through
has
contributed
to
development
community-driven
standards
guidelines,
Recommended
Metadata
Biological
Images
(REMBI),
BioModels
Reproducibility
Scorecard.
Training
is
one
EMBL-EBI’s
core
missions
key
component
provision
bioinformatics
services
users:
this
many
improvements
that
have
been
developed
online
training
offering.
Computational and Structural Biotechnology Journal,
Journal Year:
2021,
Volume and Issue:
19, P. 3892 - 3907
Published: Jan. 1, 2021
Microbes
propagate
and
thrive
in
complex
communities,
there
are
many
benefits
to
studying
engineering
microbial
communities
instead
of
single
strains.
Microbial
being
increasingly
leveraged
biotechnological
applications,
as
they
present
significant
advantages
such
the
division
labour
improved
substrate
utilisation.
Nevertheless,
also
some
interesting
challenges
surmount
for
design
efficient
processes.
In
this
review,
we
discuss
key
principles
interactions,
followed
by
a
deep
dive
into
genome-scale
metabolic
models,
focussing
on
vast
repertoire
constraint-based
modelling
methods
that
enable
us
characterise
understand
capabilities
communities.
Complementary
approaches
model
those
based
graph
theory,
briefly
discussed.
Taken
together,
these
provide
rich
insights
interactions
between
microbes
how
influence
community
productivity.
We
finally
overview
allow
generate
test
numerous
synthetic
compositions,
tools
methodologies
can
predict
effective
genetic
interventions
further
improve
productivity
With
impending
advancements
high-throughput
omics
stage
is
set
rapid
expansion
engineering,
with
impact